Science

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Malak Alharbi/LinkedIn

Feb 22, 2025, 16:00

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Malak Alharbi, PGY6 hematology oncology fellow at Roswell Park Comprehensive Cancer Center, shared an article on LinkedIn:

“Happy to share our recent publication on a case highlighting the diagnostic challenges at presentation and the therapeutic complexities of treating PRCA secondary to SMM.

We discuss the appropriate workup and explore daratumumab as a potential management option for these patients.

Thank you Dr Hillengass Jens for your support and mentorship!”

Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature.

Authors: Malak Alharbi, et al.

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

cancer Daratumumab fight against cancer Global fight against cancer Hillengass Jens Malak Alharbi multiple myeloma OncoDaily Oncology PRCA Roswell Park Comprehensive Cancer Center SMM

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen